Val (EU) xit: do we need an international ISPOR value flower?

• Sreeram V Ramagopalan,
• Manuel Gomes,
• Isabelle Durand-Zaleski,
• Bill Malcolm,
• Jose Diaz,
• Grace Mitchell,
• Jonathan Pearson-Stuttard,
• Louis P Garrison Jr

Affiliations

Sreeram V Ramagopalan

Lane Clark & Peacock LLP, London, W1U 1DQ, UK; Centre for Pharmaceutical Medicine Research, King’s College London, London, SE1 9NH, UK

Manuel Gomes

Department of Applied Health Research, University College London, London, WC1E 6BT, UK

Isabelle Durand-Zaleski

AP-HP Hotel Dieu, Clinical Research Unit Eco Ile de France, Paris, 75004, France

Bill Malcolm

Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK

Jose Diaz

Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK

Grace Mitchell

Lane Clark & Peacock LLP, London, W1U 1DQ, UK

Jonathan Pearson-Stuttard

Lane Clark & Peacock LLP, London, W1U 1DQ, UK

Louis P Garrison Jr

The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195, USA